Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 34 | 71 | 399 | 97 | 0 |
| Gross Profit | 34 | 71 | 399 | 97 | N/A |
| Operating Expenses | 10,271 | 8,897 | 21,348 | 13,072 | 12,770 |
| Operating Income | -10,237 | -8,826 | -20,949 | -12,975 | -12,770 |
| Other Income | 14 | 26 | 24 | 95 | 2,551 |
| Pre-tax Income | -10,223 | -8,800 | -20,925 | -12,880 | -10,219 |
| Net Income Continuous | -10,223 | -8,800 | -20,925 | -12,880 | -10,219 |
| Net Income | $-10,223 | $-8,800 | $-20,925 | $-12,880 | $-10,219 |
| EPS Basic Total Ops | -124,677.70 | -0.79 | -2.88 | -5.62 | -0.28 |
| EPS Basic Continuous Ops | -122,121.30 | -0.54 | -2.04 | -2.82 | -0.28 |
| EPS Diluted Total Ops | -124,677.70 | -0.79 | -2.88 | -5.62 | -0.28 |
| EPS Diluted Continuous Ops | -122,121.30 | -0.54 | -2.04 | -2.82 | -0.28 |
| EBITDA(a) | $-10,160 | $-8,739 | $-20,850 | $-12,828 | $-12,607 |